Patent details

EP2107069 Title: Novel insulin derivatives

Basic Information

Publication number:
EP2107069
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP091650721
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Novel insulin derivatives
French Title of Invention:
Nouveaux dérivés d'insuline
German Title of Invention:
Neuartige Insulinderivate
SPC Number:
92226
92213

Dates

Filing date:
22/07/2004
Grant date:
16/01/2013
EP Publication Date:
16/01/2013
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/10/2009
EP B1 Publication Date:
16/01/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
22/07/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/07/2004
 
 

Name:
NOVO NORDISK A/S
Address:
Novo Allé, 2880 Bagsværd, Denmark (DK)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
20/03/2013
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Moller Tagmose Tina
Address:
Denmark (DK)

2

Name:
Jonassen Ib
Address:
Denmark (DK)

3

Name:
Hoeg-Jensen Thomas
Address:
Denmark (DK)

4

Name:
Ribel-Madsen Ulla
Address:
Denmark (DK)

5

Name:
Havelund Svend
Address:
Denmark (DK)

6

Name:
Madsen Peter
Address:
Denmark (DK)

Priority

1

Priority Number:
200301129
Priority Date:
05/08/2003
Priority Country:
Denmark (DK)

2

Priority Number:
495451 P
Priority Date:
14/08/2003
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 14/62;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
20/06/2023
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages